NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 25 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $14,000 | +180.0% | 4,050 | 0.0% | 0.00% | – |
| Q2 2015 | $5,000 | -16.7% | 4,050 | -50.0% | 0.00% | – |
| Q1 2015 | $6,000 | +200.0% | 8,100 | +100.0% | 0.00% | – |
| Q4 2014 | $2,000 | -98.1% | 4,050 | -83.3% | 0.00% | – |
| Q3 2014 | $105,000 | -22.2% | 24,230 | -11.0% | 0.00% | – |
| Q2 2014 | $135,000 | +3.1% | 27,230 | +13.5% | 0.00% | – |
| Q1 2014 | $131,000 | +2083.3% | 24,000 | +2300.0% | 0.00% | – |
| Q4 2013 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | +40.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2013 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|